Difference between revisions of "Danaparoid (Orgaran)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Venous thromboembolism (VTE) medications" to "Category:Venous thromboembolism medications") |
m |
||
Line 15: | Line 15: | ||
[[Category:Low molecular weight heparins]] | [[Category:Low molecular weight heparins]] | ||
− | [[Category:Heparin-induced thrombocytopenia medications]] | + | [[Category:Heparin-induced thrombocytopenia medications (historic)]] |
− | [[Category:Venous thromboembolism medications]] | + | [[Category:Venous thromboembolism medications (historic)]] |
[[Category:FDA approved in 2001]] | [[Category:FDA approved in 2001]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] |
Revision as of 02:13, 29 April 2022
General information
Class/mechanism: Low molecular weight heparin
History of changes in FDA indication
- 6/26/2001: Initial FDA approval
Also known as
- Brand name: Orgaran